Definitions
Sorry, no definitions found. You may find more data at lorus.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Lorus.
Examples
-
TORONTO, ONTARIO -- 09/13/10 -- Lorus Therapeutics Inc. (TSX: LOR) (OTCBB: LRUSF) ( "Lorus"),
-
TORONTO, ONTARIO -- 03/04/10 -- Lorus Therapeutics Inc. (TSX: LOR) ( "Lorus" or the "Co.pany"), a biopharmaceutical company specializing in the discovery, research and development of pharmaceutical products and technologies for the management of cancer, today reported that Mr. Georg Ludwig, HighTech Beteiligungen GmbH
-
Lorus Therapeutics Inc. (TSX: LOR) ( "Lorus"), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, announced today that it filed a Registration Statement on Form F-1 (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC") for an offering of up to US$17,500,000 of units in the United States.
-
Lorus Therapeutics Inc. (TSX: LOR) (OTCBB: LRUSF) ( "Lorus"), a biopharmaceutical company specializing in the discovery and development of pharmaceutical products and technologies for the management of cancer, today announced the publication of a peer-reviewed scientific article describing synthesis and antibacterial activity of novel antimicrobial compounds from
-
Lorus Therapeutics Inc. (TSX: LOR) (OTCBB: LRUSF) ( "Lorus"), a biopharmaceutical company specializing in the discovery and development of pharmaceutical products and technologies for the management of cancer, today announced the approval of the Investigational New Drug (IND) application for its anticancer drug candidate LOR-253 by the U.S.
-
Lorus Therapeutics Inc. (TSX: LOR) ( "Lorus"), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, announced today that it filed a Registration Statement on Form F-1 (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC") for an offering of up to US$17,500,000 of units in the United States.
-
Lorus Therapeutics Inc. (TSX: LOR) ( "Lorus"), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, announced today that it filed a Registration Statement on Form F-1 (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC") for an offering of up to US$17,500,000 of units in the United States.
-
Lorus Therapeutics Inc. (TSX: LOR) ( "Lorus"), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, announced today that it filed a Registration Statement on Form F-1 (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC") for an offering of up to US$17,500,000 of units in the United States.
-
Lorus Therapeutics Inc. (TSX: LOR) (OTCBB: LRUSF) ( "Lorus"), a biopharmaceutical company specializing in the discovery and development of pharmaceutical products and technologies for the management of cancer, today announced the publication of a peer-reviewed scientific article describing synthesis and antibacterial activity of novel antimicrobial compounds from
-
(TSX: LOR) ( "Lorus"), a Quebec, made a $5,000 donation to the Fondation l'Actuel.
WN.com - Articles related to Take the Chicago 2016 quiz: Just follow the Olympics money 2009
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.